| ID Source | ID |
|---|---|
| PubMed CID | 9306 |
| SCHEMBL ID | 42098 |
| MeSH ID | M0485038 |
| Synonym |
|---|
| einecs 224-306-0 |
| 4298-16-2 |
| wln: 1my1r &gh -r |
| (.+-.)-madrine |
| dl-deoxyephedrine hydrochloride |
| dl-methamphetaminehydrochloride |
| benzeneethanamine,.alpha.-dimethyl-, hydrochloride, (.+-.)- |
| phenethylamine,.alpha.-dimethyl-, hydrochloride, (.+-.)- |
| dl-desoxyephedrine hydrochloride |
| dl-methamphetamine hydrochloride |
| dl-methanphetamine hydrochloride |
| dl-n-methyl-.beta.-phenylisopropylamine hydrochloride |
| (.+-.)-methamphetamine hydrochloride |
| nsc-22367 |
| nsc22367 |
| (+-)-n-methylamphetamine hydrochloride |
| c 6379 |
| methedrinal |
| psicopan |
| metamphetamin |
| levetamin |
| estimulex |
| methylbenzedrin |
| depoxin |
| einecs 206-093-6 |
| (+-)-methamphetamine hydrochloride |
| miller drine |
| doxephrin |
| psychergine |
| desfedran |
| neodrine |
| desfedrin |
| psykoton |
| 914f |
| psiquergina |
| norodrin |
| premodrin |
| phedrisox |
| methylpropamine |
| oxydrin |
| pisichergina |
| phenethylamine, n,alpha-dimethyl-, hydrochloride |
| dea oxo-5 |
| amphedroxyn |
| kemodrin |
| nsc 22367 |
| methamphin |
| oxyfed |
| methamphetamine hydrochloride, (dl) |
| noradrin |
| neopharmedrine |
| mepho-d |
| nsc 169506 |
| dopidrin |
| semoxydrine |
| phedoxe |
| oxydrene |
| lanazine |
| n-methyl-beta-phenylisopropylaminhydrochlorid [german] |
| oxydess |
| psichergina |
| amedrine |
| doxephin |
| bombita |
| daropervamin |
| normadrine |
| metamsustac |
| n,alpha-dimethylphenethylamine hydrochloride |
| amdram |
| desossiefedrina |
| dexophrine |
| methoxyn |
| amphedroxy |
| fenyprin |
| deoxyphedrine |
| (+)-n,.alpha.-dimethylphenethylamine hydrochloride |
| (+)-metamphetamine hydrochloride |
| nsc-169506 |
| dexoval hydrochloride |
| usaf el-36 |
| methedrine |
| d-n-methyl-.beta.-phenylisopropylamine hydrochloride |
| desyphed hydrochloride |
| desoxedrine |
| d-n,.alpha.-dimethylphenethylamine hydrochloride |
| des-oxa-d |
| wln: 1my1r &gh |
| (+)-methaphetamine hydrochloride |
| desamine |
| phenethylamine,.alpha.-dimethyl-, hydrochloride, (s)-(+)- |
| (+)-n-methylamphetamine hydrochloride |
| benzeneethanamine,.alpha.-dimethyl-, hydrochloride, (s)- |
| detrex |
| efroxine hydrochloride |
| (+)-methaphetamine chloride |
| nsc169506 |
| d,l-methamphetamine hcl |
| n-methyl-1-phenylpropan-2-amine hydrochloride |
| MLS002320675 |
| smr001338821 |
| 300-42-5 |
| cas-300-42-5 |
| dtxcid305544 |
| tox21_112857 |
| dtxsid3048865 , |
| 24gnz56d62 , |
| n-methyl-beta-phenylisopropylaminhydrochlorid |
| unii-24gnz56d62 |
| dl-methamphetimine hydrochloride |
| (+/-)-methamphetamine hydrochloride |
| 2-methylamino-1-phenylpropane hydrochloride |
| methamphetamine hydrochloride, dl- |
| benzeneethanamine, n,.alpha.-dimethyl-, hydrochloride |
| phenethylamine, n,.alpha.-dimethyl-, hydrochloride |
| (dl)-methamphetamine hydrochloride |
| benzeneethanamine, n,.alpha.-dimethyl-, hydrochloride (1:1) |
| metamfetamine hydrochloride, dl- |
| (+/-)-n-methylamphetamine hydrochloride |
| n,.alpha.-dimethylphenethylamine hydrochloride |
| SCHEMBL42098 |
| rac-methamphetamine hydrochloride |
| benzeneethanamine, n,a-dimethyl-, hydrochloride |
| n-methyl-1-phenylpropan-2-amine;hydrochloride |
| (+/-)-methamphetamine (hydrochloride) (crm) |
| Q27253854 |
| methyl(1-phenylpropan-2-yl)amine hydrochloride |
| d,l-methamphetamine.hcl, 1mg/ml in methanol |
| d,l-methamphetamine.hcl |
| Excerpt | Reference | Relevance |
|---|---|---|
| "The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs." | ( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019) | 0.51 |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | |||
| AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | |||
| AID1346987 | P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5 | A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
| AID1346986 | P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5 | A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
| AID1296008 | Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening | 2020 | SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1 | Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.29) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||